SIRS-Lab appoints Ed Currie as Executive Vice-President, Corporate Development
SIRS-Lab announced the appointment of Dr. Edward Currie as Executive Vice-President, Corporate Development. In this newly created role, Ed will drive partnering, licensing, companion diagnostics, and corporate business development activities at SIRS-Lab.
![SIRS-Lab](https://img.chemie.de/Portal/News/1517_Iuhg5GFAEP.jpg?tr=n-xzoom)
Ed Currie, SIRS-Lab Executive Vice-President, Corporate Development.
SIRS-Lab
Ed Currie, a physician specialized in clinical microbiology and infectious disease, brings 20 years of diagnostic and pharmaceutical industry experience at Eli Lilly, F. Hoffmann-La Roche, IBM, and, most recently, as COO of Kuros BioSurgery. At Roche, as Global Head of Disease Management, Ed created the company’s first integrated Pharma-Diagnostic approach for targeted treatment and personalized medicine.
Organizations
Other news from the department people
![Newsletter](https://img.chemie.de/assets/bionity/images/newsletter.png)
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.